RHUMBLINE ADVISERS - RAPTOR PHARMACEUTICAL CORP ownership

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q3 2016$821,000
+57.6%
91,545
-5.7%
0.00%0.0%
Q2 2016$521,000
+38.2%
97,095
+18.6%
0.00%
+100.0%
Q1 2016$377,000
-11.5%
81,849
-0.0%
0.00%0.0%
Q4 2015$426,000
-5.3%
81,869
+10.1%
0.00%
-50.0%
Q3 2015$450,000
-60.3%
74,382
+3.6%
0.00%
-50.0%
Q2 2015$1,134,000
+74.2%
71,788
+19.9%
0.00%
+100.0%
Q1 2015$651,000
+21.2%
59,858
+17.2%
0.00%0.0%
Q4 2014$537,000
+5.7%
51,083
-3.5%
0.00%0.0%
Q3 2014$508,000
-19.2%
52,958
-2.8%
0.00%0.0%
Q2 2014$629,000
+21.4%
54,458
+5.1%
0.00%0.0%
Q1 2014$518,000
-26.8%
51,812
-4.8%
0.00%0.0%
Q4 2013$708,000
-10.6%
54,412
+2.7%
0.00%0.0%
Q3 2013$792,000
+64.3%
52,982
+2.8%
0.00%0.0%
Q2 2013$482,00051,5210.00%
Other shareholders

There were no reported owners of RAPTOR PHARMACEUTICAL CORP in Q4 2016.

NameSharesValueWeighting ↓
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders